TBH Global Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

TBH Global Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$413K	Buy	7,162 +2	+0%	+$115	0.08%	204
2026 Q1	$434K	Sell	7,160 -777	-10%	-$45.3K	0.09%	188
2025 Q4	$428K	Buy	7,937 +681	+9%	+$32.8K	0.07%	179
2025 Q3	$327K	Sell	7,256 -1,674	-19%	-$78.2K	0.06%	209
2025 Q2	$413K	Buy	8,930 +57	+0.6%	+$2.8K	0.09%	139
2025 Q1	$541K	Buy	8,873 +51	+0.6%	+$2.97K	0.1%	120
2024 Q4	$499K	Buy	8,822 +2	+0%	+$112	0.12%	144
2024 Q3	$456K	Sell	8,820 -787	-8%	-$36.9K	0.1%	165
2024 Q2	$399K	Sell	9,607 -49	-0.5%	-$2.19K	0.09%	173
2024 Q1	$524K	Buy	9,656 +906	+10%	+$46.2K	0.1%	152
2023 Q4	$449K	Sell	8,750 -20,196	-70%	-$1.06M	0.09%	160
2023 Q3	$1.68M	Sell	28,946 -344	-1%	-$21.1K	0.32%	59
2023 Q2	$1.87M	Sell	29,290 -1,687	-5%	-$113K	0.37%	55
2023 Q1	$2.15M	Sell	30,977 -255	-0.8%	-$18K	0.46%	46
2022 Q4	$2.25M	Sell	31,232 -680	-2%	-$51.3K	0.55%	39
2022 Q3	$2.27M	Sell	31,912 -2,534	-7%	-$184K	0.58%	36
2022 Q2	$2.65M	Sell	34,446 -285	-0.8%	-$21.7K	0.63%	38
2022 Q1	$2.54M	Sell	34,731 -2,736	-7%	-$184K	0.54%	46
2021 Q4	$2.34M	Sell	37,467 -19,614	-34%	-$1.15M	0.48%	55
2021 Q3	$3.38M	Sell	57,081 -1,268	-2%	-$83.5K	0.78%	31
2021 Q2	$3.9M	Buy	58,349 +870	+2%	+$56.7K	0.9%	28
2021 Q1	$3.63M	Buy	57,479 +49,746	+643%	+$3.1M	0.94%	23
2020 Q4	$480K	Sell	7,733 -32	-0.4%	-$1.97K	0.15%	105
2020 Q3	$468K	Buy	7,765 +52	+0.7%	+$3.13K	0.16%	103
2020 Q2	$454K	Hold	7,713	–	–	0.18%	90
2020 Q1	$430K	Buy	7,713 +1,250	+19%	+$76.4K	0.18%	92
2019 Q4	$415K	Buy	+6,463	New	+$370K	0.12%	112

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

TBH Global Asset Management's BMY Position: Q2 2026 in Review

TBH Global Asset Management increased its Bristol-Myers Squibb (BMY) stake by 0.03% in Q2 2026, buying an estimated $115 and bringing the position to 7,162 shares worth $413K. The position accounts for 0.08% of the portfolio, ranked #204.

TBH Global Asset Management first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.9M in Q2 2021. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

TBH Global Asset Management held 7,162 shares of Bristol-Myers Squibb worth $413K as of Q2 2026.
TBH Global Asset Management bought 2 Bristol-Myers Squibb shares in Q2 2026, an estimated $115.
Bristol-Myers Squibb made up 0.08% of TBH Global Asset Management's portfolio in Q2 2026, its #204 holding.
TBH Global Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
TBH Global Asset Management's Bristol-Myers Squibb position peaked at $3.9M in Q2 2021.
2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on TBH Global Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.